Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 single-blind placebo-controlled trial of CD-NP in acute decompensated heart failure
2008-008384-10Phase 2Completed
- Sponsor
- Nile Therapeutics
- Start
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in heart failure (HF) comparing CD-NP infusion with Placebo infusion (2 arms). Primary endpoint: Safety and tolerability of CD-NP infusion. Started Mar 2009; status: completed.
02
Drugs
cenderitide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2008-008384-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008384-10.